Ticker

Company brings one of the only combined clinical and toxicological safety dataset in the hemp-derived CBD category into a new provider channel as CMS activates cannabinoid access within value-based care models CHARLOTTE, N.C., April 1, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), a leader in science-driven cannabinoid products, today announced the launch of its clinical healthcare channel, positioning the…

HEMP Act Establishes FDA Oversight, Manufacturing Standards, and Consumer Safety Requirements While Preserving Legal Market for Compliant CBD Products LOUISVILLE, Colo., Jan. 23, 2026 /PRNewswire/ - (TSX: CWEB) (OTC: CWBHF) Charlotte's Web Holdings, Inc., the industry leader in hemp-derived wellness, today commends Representative Morgan Griffith (R‑VA) for his leadership following the release of federal hemp…

NIAGARA FALLS, N.Y.--(BUSINESS WIRE)---- $CABI #CABI--Cabbacis (OTCQB: CABI), a U.S. federally-licensed tobacco-product manufacturer focused on its patented harm-reduction products being developed under the iBlend™ brand name, today announced that the United States Patent and Trademark Office has issued a patent to Cabbacis for vaporizer pods for oral electronic vaporizers. U.S. Patent No. 12,527,346, which expires…